Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Viviana De Rosa

10PUBLICATIONS

29CO-AUTHORS

Predictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Dec 11, 2025

Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)-A Preliminary In Vitro Study.

Umme Samia, Daniela Omodei, Luisa Amato

|Jul 29, 2025

Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Hamid Heydari Sheikhhossein, Luisa Amato, Viviana De Rosa

|Dec 17, 2024

Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

Luisa Amato, Daniela Omodei, Caterina De Rosa

|Sep 28, 2024

Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Luisa Amato, Caterina De Rosa, Viviana De Rosa

|May 25, 2024

Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art.

Hamid Heydari Sheikhhossein, Francesca Iommelli, Natalia Di Pietro

|Apr 27, 2024

PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.

Caterina De Rosa, Francesca Iommelli, Viviana De Rosa

Pageof 2

Frequent Collaborators

10 joint publications

Francesca Iommelli

5 joint publications

Caterina De Rosa

5 joint publications

Carminia Maria Della Corte

5 joint publications

Luisa Amato

4 joint publications

Silvana Del Vecchio

3 joint publications

Daniela Omodei

3 joint publications

Rosa Camerlingo

3 joint publications

Concetta Tuccillo

3 joint publications

Hamid Heydari Sheikhhossein

2 joint publications

Maria Cristina Curia

Frequent Collaborators

10 joint publications

Francesca Iommelli

5 joint publications

Caterina De Rosa

5 joint publications

Carminia Maria Della Corte

5 joint publications

Luisa Amato

Top Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on : Jan 19, 2019

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on : May 06, 2018

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on : Jan 19, 2019

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on : May 06, 2018

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos